- Home
- SNTI vs HUSA Comparison
SNTI vs HUSA Comparison
Compare SNTI & HUSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- HUSA
- Stock Information
- Founded
- SNTI 2016
- HUSA N/A
- Country
- SNTI United States
- HUSA United States
- Employees
- SNTI N/A
- HUSA N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- HUSA Oil & Gas Production
- Sector
- SNTI Health Care
- HUSA Energy
- Exchange
- SNTI Nasdaq
- HUSA Nasdaq
- Market Cap
- SNTI 85.3M
- HUSA 21.6M
- IPO Year
- SNTI N/A
- HUSA N/A
- Fundamental
- Price
- SNTI $2.26
- HUSA $9.57
- Analyst Decision
- SNTI Strong Buy
- HUSA
- Analyst Count
- SNTI 2
- HUSA 0
- Target Price
- SNTI $8.50
- HUSA N/A
- AVG Volume (30 Days)
- SNTI 385.8K
- HUSA 4.2M
- Earning Date
- SNTI 08-12-2025
- HUSA 08-13-2025
- Dividend Yield
- SNTI N/A
- HUSA N/A
- EPS Growth
- SNTI N/A
- HUSA N/A
- EPS
- SNTI N/A
- HUSA N/A
- Revenue
- SNTI N/A
- HUSA $514,839.00
- Revenue This Year
- SNTI N/A
- HUSA N/A
- Revenue Next Year
- SNTI $150.00
- HUSA N/A
- P/E Ratio
- SNTI N/A
- HUSA N/A
- Revenue Growth
- SNTI N/A
- HUSA N/A
- 52 Week Low
- SNTI $1.52
- HUSA $3.85
- 52 Week High
- SNTI $16.94
- HUSA $32.00
- Technical
- Relative Strength Index (RSI)
- SNTI 37.88
- HUSA 48.04
- Support Level
- SNTI $2.05
- HUSA $10.71
- Resistance Level
- SNTI $2.35
- HUSA $12.18
- Average True Range (ATR)
- SNTI 0.30
- HUSA 3.79
- MACD
- SNTI 0.00
- HUSA -0.57
- Stochastic Oscillator
- SNTI 20.00
- HUSA 1.94
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About HUSA Houston American Energy Corporation
Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Louisiana, and the South American country of Colombia. Geographically, the company currently has operations in two geographical areas, the United States, from where it derives maximum revenue, and Colombia.